Advanced search
Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Email Registration
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. Zhongsheng Group Holdings Limited
  6. News
  7. Summary
    881   KYG9894K1085

ZHONGSHENG GROUP HOLDINGS LIMITED

(881)
  Report
Delayed Hong Kong Stock Exchange  -  11:56:37 2023-05-30 pm EDT
28.70 HKD   +0.17%
05/22Zhongsheng Pharm Unit Enrolls First Subject for RAY1225 Injection Trial
MT
04/27Zhongsheng Group Holdings Limited Proposes Final Dividend for the Year Ended 31 December 2022
CI
04/26Zhongsheng Group Partially Redeems 2025 Convertible Bonds
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Zhongsheng : Nomura Downgrades Zhongsheng Group to Neutral From Buy, Adjusts Price Target to HK$79 From HK$56.5

08/11/2021 | 05:46am EDT
share with twitter
share with LinkedIn
share with facebook


© MT Newswires 2021
All news about ZHONGSHENG GROUP HOLDINGS LIMITED
05/22Zhongsheng Pharm Unit Enrolls First Subject for RAY1225 Injection Trial
MT
04/27Zhongsheng Group Holdings Limited Proposes Final Dividend for the Year Ended 31 Decembe..
CI
04/26Zhongsheng Group Partially Redeems 2025 Convertible Bonds
MT
03/27Zhongsheng Pharma Gets Conditional Market Approval For Oral COVID-19 Drug
MT
03/23Zhongsheng Group Holdings Limited Announces Change of Composition of Board Committees
CI
03/23Zhongsheng Group's 2022 Profit Falls 19.9%
MT
03/22Zhongsheng Group Holdings Limited Proposes Final Dividend for the Year Ended 31 Decembe..
CI
03/22Zhongsheng Group Holdings Limited Reports Earnings Results for the Full Year Ended Dece..
CI
03/16Guangdong Zhongsheng Pharmaceutical Enrolls Patients in Clinical Trial of Flu Drug
MT
03/14Guangdong Zhongsheng Pharm Gets Nod to Trial Diabetes Drug
MT
More news
Analyst Recommendations on ZHONGSHENG GROUP HOLDINGS LIMITED
More recommendations
Financials
Sales 2023 199 B 28 172 M 28 172 M
Net income 2023 8 115 M 1 146 M 1 146 M
Net Debt 2023 4 381 M 619 M 619 M
P/E ratio 2023 7,98x
Yield 2023 4,17%
Capitalization 61 982 M 8 755 M 8 755 M
EV / Sales 2023 0,33x
EV / Sales 2024 0,29x
Nbr of Employees 32 943
Free-Float 29,3%
Chart ZHONGSHENG GROUP HOLDINGS LIMITED
Duration : Period :
Zhongsheng Group Holdings Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ZHONGSHENG GROUP HOLDINGS LIMITED
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 19
Last Close Price 25,89 CNY
Average target price 44,07 CNY
Spread / Average Target 70,2%
EPS Revisions
Managers and Directors
Guo Qiang Li President, Chief Executive Officer & Vice Chairman
Ning Yu Joint Chief Financial Officer
Yi Huang Chairman
Jin Jun Shen Independent Non-Executive Director
Wei Ying Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
ZHONGSHENG GROUP HOLDINGS LIMITED-29.51%8 654
PENSKE AUTOMOTIVE GROUP, INC.23.20%9 770
D'IETEREN GROUP-8.20%9 369
AUTONATION, INC.31.03%6 262
ASBURY AUTOMOTIVE GROUP, INC.20.76%4 578
RUSH ENTERPRISES, INC.4.39%2 983
-40% off: Our subscriptions help you unlock hidden opportunities!
Subscribe
fermer